Controversies in Establishing Biosimilarity: Extrapolation of Indications and Global Labeling Practices Hans C. EbbersPaul Chamberlain Current Opinion Open access 13 January 2016 Pages: 1 - 8
Immunomodulating Drugs Based on Poxviral Proteins Galina A. ShchelkunovaSergei N. Shchelkunov Review Article 28 January 2016 Pages: 9 - 16
Pharmacokinetic Bioequivalence, Safety, and Immunogenicity of DMB-3111, a Trastuzumab Biosimilar, and Trastuzumab in Healthy Japanese Adult Males: Results of a Randomized Trial Jun MoritaMasashi TanakaMasanari Shiramoto Original Research Article Open access 21 December 2015 Pages: 17 - 25
Switching Between Epoetins: A Practice in Support of Biosimilar Use Carmen D’AmoreRoberto Da CasGiuseppe Traversa Original Research Article Open access 04 January 2016 Pages: 27 - 32
A Retrospective Study on the Efficacy of Trastuzumab in HER2-Positive and Tamoxifen-Refractory Breast Cancer with Brain Metastasis Chongjian ZhangLu WangShude Cui Original Research Article 20 January 2016 Pages: 33 - 40
Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA Lesley J. Scott Adis Drug Evaluation 01 February 2016 Pages: 41 - 48